KLOTHO KL‐VS genotype modifies the relationship between cardiorespiratory fitness and CSF biomarkers of neurodegeneration, synaptic dysfunction, and inflammation

Abstract Background Less adequate cardiorespiratory fitness (CRF) is associated with several aspects of Alzheimer’s disease (AD) pathology, including neuroinflammation, neurodegeneration and synaptic dysfunction, all of which are known contributors to the clinical outcome – progressive cognitive decline [1]. AD‐associated biomolecular changes also seem to be attenuated in carriers of the functionally advantageous variant of the KLOTHO gene (KL‐VS HET ) [2]. While KL‐VS HET and CRF both appear to mitigate aspects of AD pathology, they have been exclusively studied in isolation. Here we investigate whether the relationships between CRF (VO 2 max) and cerebrospinal fluid (CSF) biomarkers of neurodegeneration, synaptic dysfunction, and inflammation differ for KL‐VS HET compared to non‐carriers (KL‐VS NC ). Method The cohort, enriched for AD risk, consisted of cognitively unimpaired adults (N=132; Mean AGE =62.7) from the Wisconsin Registry for Alzheimer’s Prevention and Wisconsin Alzheimer’s Disease Research Center. Covariate‐adjusted (age, sex, parental AD history, APOE, and age difference between CSF sampling and exercise test) linear models examined the relationship between VO 2 max and CSF biomarkers of neurodegeneration [α‐synuclein (α‐syn), neurofilament light polypeptide (NfL), total tau (tTau)], synaptic dysfunction [neurogranin (Ng)], and neuroinflammation [glial fibrillary acidic protein (GFAP), soluble triggering receptor expressed in myeloid cells (sTREM2), chitinase‐3‐like protein 1 (YKL‐40), interleukin 6 (IL‐6), S100 calcium‐binding protein B (S100B)] as a function of KLOTHO KL‐VS. Result The interaction between VO 2 max and KL‐VS HET was significant for tTau (P=0.05), Ng (P=0.02), sTREM2 (P=0.02), and YKL‐40 (P=0.03) (Table 1; Figure 1), such that KL‐VS HET who were more fit had significantly lower levels of tTau, Ng, sTREM2, and YKL‐40 but not α‐syn, NfL, GFAP, IL‐6, or S100B (all Ps>0.63). Conclusion We report a synergistic relationship between KL‐VS HET and CRF with regard to neurodegeneration (tTau), synaptic dysfunction (Ng) and inflammation (sTREM2 and YKL‐40), suggesting a protective role for both KL‐VS HET and better cardiovascular fitness against unfavorable AD‐related changes. Their potentially shared biological mechanisms will require future investigations. References [1] Huuha, A.M., et al., Can exercise training teach us how to treat Alzheimer's disease? Ageing Res Rev, 2022. 75: p. 101559. [2] Driscoll, I., et al., AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes. Alzheimers Dement (Amst), 2022. 14(1): p. e12383.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.086169
Primary Topic
Adipose Tissue and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

KLOTHO KL‐VS genotype modifies the relationship between cardiorespiratory fitness and CSF biomarkers of neurodegeneration, synaptic dysfunction, and inflammation

Bruce P. Hermann, Dena B. Dubal, Dane B. Cook, Catherine L. Gallagher et al.
Alzheimer s & Dementia
Adipose Tissue and Metabolism
article

KLOTHO KL‐VS genotype modifies the relationship between cardiorespiratory fitness and CSF biomarkers of neurodegeneration, synaptic dysfunction, and inflammation

Bruce P. Hermann, Dena B. Dubal, Dane B. Cook, Catherine L. Gallagher, Brianne M. Breidenbach, Gwendlyn Kollmorgen, Kaj Blennow, Henrik Zetterberg, Ira Driscoll, N. Cook, Sterling C. Johnson, Mackenzie Jarchow, Clara Quijano‐Rubio, Ozioma C. Okonkwo, Sanjay Asthana, Mark A. Sager, Cynthia M. Carlsson
article en

Abstract

Abstract Background Less adequate cardiorespiratory fitness (CRF) is associated with several aspects of Alzheimer’s disease (AD) pathology, including neuroinflammation, neurodegeneration and synaptic dysfunction, all of which are known contributors to the clinical outcome – progressive cognitive decline [1]. AD‐associated biomolecular changes also seem to be attenuated in carriers of the functionally advantageous variant of the KLOTHO gene (KL‐VS HET ) [2]. While KL‐VS HET and CRF both appear to mitigate aspects of AD pathology, they have been exclusively studied in isolation. Here we investigate whether the relationships between CRF (VO 2 max) and cerebrospinal fluid (CSF) biomarkers of neurodegeneration, synaptic dysfunction, and inflammation differ for KL‐VS HET compared to non‐carriers (KL‐VS NC ). Method The cohort, enriched for AD risk, consisted of cognitively unimpaired adults (N=132; Mean AGE =62.7) from the Wisconsin Registry for Alzheimer’s Prevention and Wisconsin Alzheimer’s Disease Research Center. Covariate‐adjusted (age, sex, parental AD history, APOE, and age difference between CSF sampling and exercise test) linear models examined the relationship between VO 2 max and CSF biomarkers of neurodegeneration [α‐synuclein (α‐syn), neurofilament light polypeptide (NfL), total tau (tTau)], synaptic dysfunction [neurogranin (Ng)], and neuroinflammation [glial fibrillary acidic protein (GFAP), soluble triggering receptor expressed in myeloid cells (sTREM2), chitinase‐3‐like protein 1 (YKL‐40), interleukin 6 (IL‐6), S100 calcium‐binding protein B (S100B)] as a function of KLOTHO KL‐VS. Result The interaction between VO 2 max and KL‐VS HET was significant for tTau (P=0.05), Ng (P=0.02), sTREM2 (P=0.02), and YKL‐40 (P=0.03) (Table 1; Figure 1), such that KL‐VS HET who were more fit had significantly lower levels of tTau, Ng, sTREM2, and YKL‐40 but not α‐syn, NfL, GFAP, IL‐6, or S100B (all Ps>0.63). Conclusion We report a synergistic relationship between KL‐VS HET and CRF with regard to neurodegeneration (tTau), synaptic dysfunction (Ng) and inflammation (sTREM2 and YKL‐40), suggesting a protective role for both KL‐VS HET and better cardiovascular fitness against unfavorable AD‐related changes. Their potentially shared biological mechanisms will require future investigations. References [1] Huuha, A.M., et al., Can exercise training teach us how to treat Alzheimer's disease? Ageing Res Rev, 2022. 75: p. 101559. [2] Driscoll, I., et al., AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes. Alzheimers Dement (Amst), 2022. 14(1): p. e12383.

Alzheimer s & DementiaVol. 20(S2)
Roche (Switzerland) (CH), University of Science and Technology of China (CN), Alzheimer's Association (US), University of Wisconsin–Madison (US), University of California, San Francisco (US), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Roche Pharma AG (Germany) (DE), Geriatric Research Education and Clinical Center (US), Pitié-Salpêtrière Hospital (FR), National Hospital for Neurology and Neurosurgery (GB), Institut du Cerveau (FR), University College London (GB), University of Gothenburg (SE)
Good health and well-being
Openalex Percentile: Top 65%
Adipose Tissue and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.